Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation
- PMID: 16500920
- DOI: 10.1152/ajpgi.00324.2005
Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation
Abstract
H2S is highly toxic and selectively inhibits butyrate oxidation in colonocytes. Ineffective detoxification may result in mucosal insult, inflammation, and ultimately in colorectal cancer (CRC). Rhodanese can detoxify H2S and is comprised of two isoenzymes: thiosulfate sulfurtransferase (TST) and mercaptopyruvate sulfurtransferase (MST). Using specific antisera to discriminate TST from MST, we found that only TST could detoxify H2S. In sections of normal colon, both enzymes were located on the luminal mucosal surface, and they were expressed in the colonocytes but not in the mucin-secreting goblet cells. Expression of both enzymes was focally lost in ulcerative colitis and markedly reduced in advanced colon cancer, the disease progression correlating with the decreased expression of MST and TST. In HT-29 cells, a human colon cancer cell line, TST activity and expression were significantly increased by butyrate and by histone deacetylase inhibition, agents that promote HT-29 cell differentiation. Sulfide (0.1 mM) also increased TST activity, but higher sulfide concentrations (0.3-3 mM) were toxic. Preincubation in butyrate to increase TST expression, decreased sensitivity of the cells to sulfide toxicity. We conclude that decreased expression of TST (or MST) is a tumor marker for CRC. TST expression is increased in colonocyte differentiation. Dysregulation of TST expression and activity resulting in inability to effectively detoxify could be a factor in the cell loss and inflammation that accompany ulcerative colitis and ultimately then in CRC.
Similar articles
-
Rhodanese, but not cystathionine-gamma-lyase, is associated with dextran sulfate sodium-evoked colitis in mice: a sign of impaired colonic sulfide detoxification?Toxicology. 2009 Oct 1;264(1-2):96-103. doi: 10.1016/j.tox.2009.07.018. Epub 2009 Jul 30. Toxicology. 2009. PMID: 19647029
-
Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells.Biochem Pharmacol. 2018 Mar;149:174-185. doi: 10.1016/j.bcp.2017.10.007. Epub 2017 Oct 20. Biochem Pharmacol. 2018. PMID: 29061341 Free PMC article.
-
Detoxification of H(2)S by differentiated colonic epithelial cells: implication of the sulfide oxidizing unit and of the cell respiratory capacity.Antioxid Redox Signal. 2012 Jul 1;17(1):1-10. doi: 10.1089/ars.2011.4186. Epub 2012 Apr 17. Antioxid Redox Signal. 2012. PMID: 22369066
-
Luminal sulfide and large intestine mucosa: friend or foe?Amino Acids. 2010 Jul;39(2):335-47. doi: 10.1007/s00726-009-0445-2. Epub 2009 Dec 18. Amino Acids. 2010. PMID: 20020161 Review.
-
Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre.Mutat Res. 2009 Jul-Aug;682(1):39-53. doi: 10.1016/j.mrrev.2009.04.001. Epub 2009 Apr 19. Mutat Res. 2009. PMID: 19383551 Review.
Cited by
-
Gut microbiome influences efficacy of Endostatin combined with PD-1 blockade against colorectal cancer.Mol Biomed. 2024 Sep 10;5(1):37. doi: 10.1186/s43556-024-00200-3. Mol Biomed. 2024. PMID: 39251538 Free PMC article.
-
Progress of near-infrared-II fluorescence in precision diagnosis and treatment of colorectal cancer.Heliyon. 2023 Dec 3;9(12):e23209. doi: 10.1016/j.heliyon.2023.e23209. eCollection 2023 Dec. Heliyon. 2023. PMID: 38149207 Free PMC article. Review.
-
Mechanisms by which the intestinal microbiota affects gastrointestinal tumours and therapeutic effects.Mol Biomed. 2023 Nov 30;4(1):45. doi: 10.1186/s43556-023-00157-9. Mol Biomed. 2023. PMID: 38032415 Free PMC article. Review.
-
Association between sulfur microbial diet and the risk of colorectal cancer precursors in older adults.Front Nutr. 2023 Aug 14;10:1167372. doi: 10.3389/fnut.2023.1167372. eCollection 2023. Front Nutr. 2023. PMID: 37645627 Free PMC article.
-
Role of Hydrogen Sulfide in Inflammatory Bowel Disease.Antioxidants (Basel). 2023 Aug 6;12(8):1570. doi: 10.3390/antiox12081570. Antioxidants (Basel). 2023. PMID: 37627565 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources